PubMed:32882331
Annnotations
sonoma2
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T29 | 543-557 | DISEASE | denotes | cardiovascular |
| T30 | 543-580 | DISEASE | denotes | cardiovascular and pulmonary diseases |
| T31 | 562-580 | DISEASE | denotes | pulmonary diseases |
| T32 | 602-612 | REG | denotes | contribute |
| T33 | 620-627 | CPA | denotes | outcome |
| T34 | 631-639 | DISEASE | denotes | COVID-19 |
| T35 | 656-664 | DISEASE | denotes | COVID-19 |
| T36 | 749-753 | GENE | denotes | ACE1 |
| T37 | 754-772 | VAR | denotes | insertion/deletion |
| T38 | 777-781 | GENE | denotes | ACE2 |
| T0 | 0-30 | GENE | denotes | Angiotensin-converting enzymes |
| T1 | 32-35 | GENE | denotes | ACE |
| T2 | 37-41 | GENE | denotes | ACE2 |
| T3 | 48-56 | VAR | denotes | variants |
| T4 | 61-69 | DISEASE | denotes | COVID-19 |
| T5 | 70-77 | CPA | denotes | outcome |
| T6 | 105-115 | REG | denotes | implicated |
| T7 | 123-135 | MPA | denotes | pathogenesis |
| T8 | 139-147 | DISEASE | denotes | COVID-19 |
| T9 | 156-160 | GENE | denotes | ACE2 |
| T10 | 168-185 | MPA | denotes | cellular receptor |
| T11 | 206-216 | MPA | denotes | expression |
| T12 | 224-228 | GENE | denotes | ACE2 |
| T13 | 240-248 | REG | denotes | regulate |
| T14 | 265-279 | MPA | denotes | susceptibility |
| T15 | 283-292 | DISEASE | denotes | infection |
| T16 | 327-331 | GENE | denotes | ACE1 |
| T17 | 336-340 | GENE | denotes | ACE2 |
| T18 | 341-349 | MPA | denotes | activity |
| T19 | 359-369 | REG | denotes | implicated |
| T20 | 377-389 | MPA | denotes | pathogenesis |
| T21 | 393-413 | DISEASE | denotes | respiratory diseases |
| T22 | 424-428 | REG | denotes | play |
| T23 | 431-435 | REG | denotes | role |
| T24 | 443-451 | MPA | denotes | severity |
| T39 | 782-804 | VAR | denotes | rs2285666 polymorphism |
| T40 | 923-927 | GENE | denotes | ACE2 |
| T41 | 971-986 | DISEASE | denotes | Severe COVID-19 |
| T42 | 978-986 | DISEASE | denotes | COVID-19 |
| T43 | 991-1001 | REG | denotes | associated |
| T44 | 1007-1019 | DISEASE | denotes | hypertension |
| T45 | 1045-1057 | DISEASE | denotes | hypertension |
| T46 | 1071-1092 | DISEASE | denotes | hypercholesterolaemia |
| T47 | 1114-1121 | GENE | denotes | ACE1-DD |
| T48 | 1122-1130 | VAR | denotes | genotype |
| T49 | 1180-1192 | DISEASE | denotes | hypertension |
| T50 | 1328-1338 | REG | denotes | predictors |
| T51 | 1342-1350 | CPA | denotes | severity |
| T52 | 1356-1360 | GENE | denotes | ACE2 |
| T53 | 1361-1373 | VAR | denotes | polymorphism |
| T54 | 1382-1392 | REG | denotes | associated |
| T55 | 1402-1417 | MPA | denotes | disease outcome |
| T56 | 1423-1427 | GENE | denotes | ACE2 |
| T57 | 1465-1473 | VAR | denotes | variants |
| T58 | 1485-1492 | REG | denotes | explain |
| T59 | 1496-1505 | POSREG | denotes | increased |
| T60 | 1525-1533 | DISEASE | denotes | COVID-19 |
| T61 | 1553-1560 | POSREG | denotes | adverse |
| T62 | 1561-1568 | CPA | denotes | outcome |
| T63 | 1572-1580 | DISEASE | denotes | COVID-19 |
| T64 | 1585-1595 | REG | denotes | associated |
| T65 | 1614-1626 | DISEASE | denotes | hypertension |
| T66 | 1628-1648 | DISEASE | denotes | hypercholesterolemia |
| T67 | 1657-1661 | GENE | denotes | ACE1 |
| T68 | 1662-1670 | VAR | denotes | genotype |
| T69 | 1700-1708 | GENE | denotes | ACE1-I/D |
| T70 | 1715-1724 | REG | denotes | influence |
| T71 | 1725-1733 | DISEASE | denotes | COVID-19 |
| T72 | 1734-1742 | MPA | denotes | severity |
| T73 | 1752-1758 | REG | denotes | effect |
| T74 | 1763-1772 | REG | denotes | dependent |
| T75 | 1780-1792 | DISEASE | denotes | hypertensive |
| T25 | 455-463 | DISEASE | denotes | COVID-19 |
| T26 | 476-485 | GENE | denotes | ACE1/ACE2 |
| T27 | 491-504 | VAR | denotes | polymorphisms |
| T28 | 515-525 | REG | denotes | associated |
| R14 | T15 | T14 | ThemeOf | infection,susceptibility |
| R15 | T15 | T13 | ThemeOf | infection,regulate |
| R36 | T27 | T33 | CauseOf | polymorphisms,outcome |
| R37 | T29 | T28 | ThemeOf | cardiovascular,associated |
| R38 | T29 | T32 | ThemeOf | cardiovascular,contribute |
| R39 | T31 | T28 | ThemeOf | pulmonary diseases,associated |
| R40 | T31 | T32 | ThemeOf | pulmonary diseases,contribute |
| R41 | T33 | T32 | ThemeOf | outcome,contribute |
| R42 | T34 | T33 | ThemeOf | COVID-19,outcome |
| R43 | T34 | T32 | ThemeOf | COVID-19,contribute |
| R44 | T36 | T37 | ThemeOf | ACE1,insertion/deletion |
| R45 | T36 | T39 | ThemeOf | ACE1,rs2285666 polymorphism |
| R46 | T38 | T37 | ThemeOf | ACE2,insertion/deletion |
| R47 | T38 | T39 | ThemeOf | ACE2,rs2285666 polymorphism |
| R48 | T41 | T43 | ThemeOf | Severe COVID-19,associated |
| R49 | T48 | T43 | CauseOf | genotype,associated |
| R50 | T51 | T50 | ThemeOf | severity,predictors |
| R51 | T52 | T53 | ThemeOf | ACE2,polymorphism |
| R52 | T53 | T54 | CauseOf | polymorphism,associated |
| R53 | T53 | T55 | CauseOf | polymorphism,disease outcome |
| R54 | T55 | T54 | ThemeOf | disease outcome,associated |
| R55 | T56 | T57 | ThemeOf | ACE2,variants |
| R56 | T57 | T58 | CauseOf | variants,explain |
| R57 | T57 | T59 | CauseOf | variants,increased |
| R58 | T60 | T58 | ThemeOf | COVID-19,explain |
| R59 | T60 | T59 | ThemeOf | COVID-19,increased |
| R0 | T0 | T3 | ThemeOf | Angiotensin-converting enzymes,variants |
| R1 | T1 | T3 | ThemeOf | ACE,variants |
| R2 | T2 | T3 | ThemeOf | ACE2,variants |
| R3 | T7 | T6 | ThemeOf | pathogenesis,implicated |
| R4 | T8 | T7 | ThemeOf | COVID-19,pathogenesis |
| R5 | T8 | T6 | ThemeOf | COVID-19,implicated |
| R6 | T9 | T10 | ThemeOf | ACE2,cellular receptor |
| R7 | T9 | T11 | ThemeOf | ACE2,expression |
| R8 | T11 | T10 | ThemeOf | expression,cellular receptor |
| R9 | T10 | T13 | ThemeOf | cellular receptor,regulate |
| R10 | T11 | T13 | ThemeOf | expression,regulate |
| R11 | T12 | T10 | ThemeOf | ACE2,cellular receptor |
| R12 | T12 | T11 | ThemeOf | ACE2,expression |
| R13 | T14 | T13 | ThemeOf | susceptibility,regulate |
| R16 | T18 | T19 | ThemeOf | activity,implicated |
| R17 | T20 | T19 | ThemeOf | pathogenesis,implicated |
| R18 | T21 | T20 | ThemeOf | respiratory diseases,pathogenesis |
| R19 | T20 | T22 | ThemeOf | pathogenesis,play |
| R20 | T20 | T23 | ThemeOf | pathogenesis,role |
| R21 | T24 | T20 | ThemeOf | severity,pathogenesis |
| R22 | T21 | T19 | ThemeOf | respiratory diseases,implicated |
| R23 | T21 | T22 | ThemeOf | respiratory diseases,play |
| R24 | T21 | T23 | ThemeOf | respiratory diseases,role |
| R25 | T23 | T22 | ThemeOf | role,play |
| R26 | T24 | T19 | ThemeOf | severity,implicated |
| R27 | T24 | T22 | ThemeOf | severity,play |
| R28 | T24 | T23 | ThemeOf | severity,role |
| R29 | T25 | T24 | ThemeOf | COVID-19,severity |
| R30 | T25 | T19 | ThemeOf | COVID-19,implicated |
| R31 | T25 | T22 | ThemeOf | COVID-19,play |
| R32 | T25 | T23 | ThemeOf | COVID-19,role |
| R33 | T26 | T27 | ThemeOf | ACE1/ACE2,polymorphisms |
| R34 | T27 | T28 | CauseOf | polymorphisms,associated |
| R35 | T27 | T32 | CauseOf | polymorphisms,contribute |
| R60 | T62 | T61 | ThemeOf | outcome,adverse |
| R61 | T63 | T62 | ThemeOf | COVID-19,outcome |
| R62 | T62 | T64 | ThemeOf | outcome,associated |
| R63 | T63 | T61 | ThemeOf | COVID-19,adverse |
| R64 | T63 | T64 | ThemeOf | COVID-19,associated |
| R65 | T67 | T68 | ThemeOf | ACE1,genotype |
| R66 | T68 | T61 | CauseOf | genotype,adverse |
| R67 | T68 | T64 | CauseOf | genotype,associated |
| R68 | T71 | T70 | ThemeOf | COVID-19,influence |
| R69 | T71 | T72 | ThemeOf | COVID-19,severity |
| R70 | T71 | T73 | ThemeOf | COVID-19,effect |
| R71 | T71 | T74 | ThemeOf | COVID-19,dependent |
| R72 | T72 | T70 | ThemeOf | severity,influence |
| R73 | T72 | T73 | ThemeOf | severity,effect |
| R74 | T72 | T74 | ThemeOf | severity,dependent |
| R75 | T73 | T74 | ThemeOf | effect,dependent |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T1 | 43-47 | Body_part | denotes | gene | http://purl.org/sig/ont/fma/fma74402 |
| T2 | 229-233 | Body_part | denotes | gene | http://purl.org/sig/ont/fma/fma74402 |
| T3 | 486-490 | Body_part | denotes | gene | http://purl.org/sig/ont/fma/fma74402 |
| T4 | 935-946 | Body_part | denotes | nucleotides | http://purl.org/sig/ont/fma/fma82740 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 61-69 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T2 | 139-147 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T3 | 190-198 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T4 | 283-292 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T5 | 393-413 | Disease | denotes | respiratory diseases | http://purl.obolibrary.org/obo/MONDO_0005087 |
| T6 | 455-463 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T7 | 562-580 | Disease | denotes | pulmonary diseases | http://purl.obolibrary.org/obo/MONDO_0005275 |
| T8 | 631-639 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T9 | 656-664 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T10 | 978-986 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T11 | 1007-1019 | Disease | denotes | hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
| T12 | 1045-1057 | Disease | denotes | hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
| T13 | 1119-1121 | Disease | denotes | DD | http://purl.obolibrary.org/obo/MONDO_0009107|http://purl.obolibrary.org/obo/MONDO_0015613 |
| T15 | 1180-1192 | Disease | denotes | hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
| T16 | 1525-1533 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T17 | 1572-1580 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T18 | 1614-1626 | Disease | denotes | hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
| T19 | 1725-1733 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 43-47 | http://purl.obolibrary.org/obo/OGG_0000000002 | denotes | gene |
| T2 | 229-233 | http://purl.obolibrary.org/obo/OGG_0000000002 | denotes | gene |
| T3 | 341-349 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
| T4 | 350-353 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T5 | 429-430 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T6 | 486-490 | http://purl.obolibrary.org/obo/OGG_0000000002 | denotes | gene |
| T7 | 950-951 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T8 | 1020-1024 | http://purl.obolibrary.org/obo/UBERON_0003101 | denotes | male |
| T9 | 1020-1024 | http://www.ebi.ac.uk/efo/EFO_0000970 | denotes | male |
| T10 | 1238-1242 | http://purl.obolibrary.org/obo/UBERON_0003101 | denotes | male |
| T11 | 1238-1242 | http://www.ebi.ac.uk/efo/EFO_0000970 | denotes | male |
| T12 | 1601-1605 | http://purl.obolibrary.org/obo/UBERON_0003101 | denotes | male |
| T13 | 1601-1605 | http://www.ebi.ac.uk/efo/EFO_0000970 | denotes | male |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1 | 0-11 | Chemical | denotes | Angiotensin | http://purl.obolibrary.org/obo/CHEBI_2719 |
| T2 | 83-94 | Chemical | denotes | Angiotensin | http://purl.obolibrary.org/obo/CHEBI_2719 |
| T3 | 935-946 | Chemical | denotes | nucleotides | http://purl.obolibrary.org/obo/CHEBI_36976 |
| T4 | 952-957 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T5 | 1020-1024 | Chemical | denotes | male | http://purl.obolibrary.org/obo/CHEBI_30780 |
| T6 | 1119-1121 | Chemical | denotes | DD | http://purl.obolibrary.org/obo/CHEBI_73446 |
| T7 | 1238-1242 | Chemical | denotes | male | http://purl.obolibrary.org/obo/CHEBI_30780 |
| T8 | 1601-1605 | Chemical | denotes | male | http://purl.obolibrary.org/obo/CHEBI_30780 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 123-135 | http://purl.obolibrary.org/obo/GO_0009405 | denotes | pathogenesis |
| T2 | 377-389 | http://purl.obolibrary.org/obo/GO_0009405 | denotes | pathogenesis |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-78 | Sentence | denotes | Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome. |
| T2 | 79-148 | Sentence | denotes | The Angiotensin system is implicated in the pathogenesis of COVID-19. |
| T3 | 149-293 | Sentence | denotes | First, ACE2 is the cellular receptor for SARS-CoV-2, and expression of the ACE2 gene could regulate the individuaĺs susceptibility to infection. |
| T4 | 294-464 | Sentence | denotes | In addition, the balance between ACE1 and ACE2 activity has been implicated in the pathogenesis of respiratory diseases and could play a role in the severity of COVID-19. |
| T5 | 465-640 | Sentence | denotes | Functional ACE1/ACE2 gene polymorphisms have been associated with the risk of cardiovascular and pulmonary diseases, and could thus also contribute to the outcome of COVID-19. |
| T6 | 641-744 | Sentence | denotes | We studied 204 COVID-19 patients (137 non-severe and 67 severe-ICU cases) and 536 age-matched controls. |
| T7 | 745-821 | Sentence | denotes | The ACE1 insertion/deletion and ACE2 rs2285666 polymorphism were determined. |
| T8 | 822-900 | Sentence | denotes | Variables frequencies were compared between the groups by logistic regression. |
| T9 | 901-970 | Sentence | denotes | We also sequenced the ACE2 coding nucleotides in a group of patients. |
| T10 | 971-1143 | Sentence | denotes | Severe COVID-19 was associated with hypertension male gender (p < 0.001), hypertension (p = 0.006), hypercholesterolaemia (p = 0.046), and the ACE1-DD genotype (p = 0.049). |
| T11 | 1144-1351 | Sentence | denotes | In the multiple logistic regression hypertension (p = 0.02, OR = 2.26, 95%CI = 1.12-4.63) and male gender (p = 0.002; OR = 3.15, 95%CI = 1.56-6.66) remained as independent significant predictors of severity. |
| T12 | 1352-1418 | Sentence | denotes | The ACE2 polymorphism was not associated with the disease outcome. |
| T13 | 1419-1534 | Sentence | denotes | The ACE2 sequencing showed no coding sequence variants that could explain an increased risk of developing COVID-19. |
| T14 | 1535-1671 | Sentence | denotes | In conclusion, an adverse outcome of COVID-19 was associated with male gender, hypertension, hypercholesterolemia and the ACE1 genotype. |
| T15 | 1672-1800 | Sentence | denotes | Our work suggested that the ACE1-I/D might influence COVID-19 severity, but the effect was dependent on the hypertensive status. |
| T16 | 1801-1864 | Sentence | denotes | This result requires further validation in other large cohorts. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id | tao:has_standard_notation |
|---|---|---|---|---|---|---|
| 4 | 0-30 | Gene | denotes | Angiotensin-converting enzymes | Gene:1636 | |
| 5 | 32-35 | Gene | denotes | ACE | Gene:1636 | |
| 6 | 37-41 | Gene | denotes | ACE2 | Gene:59272 | |
| 7 | 61-69 | Disease | denotes | COVID-19 | MESH:C000657245 | |
| 44 | 139-147 | Disease | denotes | COVID-19 | MESH:C000657245 | |
| 45 | 156-160 | Gene | denotes | ACE2 | Gene:59272 | |
| 46 | 190-200 | Species | denotes | SARS-CoV-2 | Tax:2697049 | |
| 47 | 224-228 | Gene | denotes | ACE2 | Gene:59272 | |
| 48 | 283-292 | Disease | denotes | infection | MESH:D007239 | |
| 49 | 327-331 | Gene | denotes | ACE1 | Gene:1636 | |
| 50 | 336-340 | Gene | denotes | ACE2 | Gene:59272 | |
| 51 | 393-413 | Disease | denotes | respiratory diseases | MESH:D012140 | |
| 52 | 455-463 | Disease | denotes | COVID-19 | MESH:C000657245 | |
| 53 | 476-480 | Gene | denotes | ACE1 | Gene:1636 | |
| 54 | 481-485 | Gene | denotes | ACE2 | Gene:59272 | |
| 55 | 543-580 | Disease | denotes | cardiovascular and pulmonary diseases | MESH:D002318 | |
| 56 | 631-639 | Disease | denotes | COVID-19 | MESH:C000657245 | |
| 57 | 656-664 | Disease | denotes | COVID-19 | MESH:C000657245 | |
| 58 | 665-673 | Species | denotes | patients | Tax:9606 | |
| 59 | 749-753 | Gene | denotes | ACE1 | Gene:1636 | |
| 60 | 777-781 | Gene | denotes | ACE2 | Gene:59272 | |
| 61 | 782-791 | Mutation | denotes | rs2285666 | rs2285666 | |
| 62 | 923-927 | Gene | denotes | ACE2 | Gene:59272 | |
| 63 | 961-969 | Species | denotes | patients | Tax:9606 | |
| 64 | 978-986 | Disease | denotes | COVID-19 | MESH:C000657245 | |
| 65 | 1007-1019 | Disease | denotes | hypertension | MESH:D006973 | |
| 66 | 1045-1057 | Disease | denotes | hypertension | MESH:D006973 | |
| 67 | 1071-1092 | Disease | denotes | hypercholesterolaemia | ||
| 68 | 1114-1118 | Gene | denotes | ACE1 | Gene:1636 | |
| 69 | 1180-1192 | Disease | denotes | hypertension | MESH:D006973 | |
| 70 | 1356-1360 | Gene | denotes | ACE2 | Gene:59272 | |
| 71 | 1423-1427 | Gene | denotes | ACE2 | Gene:59272 | |
| 72 | 1525-1533 | Disease | denotes | COVID-19 | MESH:C000657245 | |
| 73 | 1572-1580 | Disease | denotes | COVID-19 | MESH:C000657245 | |
| 74 | 1614-1626 | Disease | denotes | hypertension | MESH:D006973 | |
| 75 | 1628-1648 | Disease | denotes | hypercholesterolemia | MESH:D006937 | |
| 76 | 1657-1661 | Gene | denotes | ACE1 | Gene:1636 | |
| 77 | 1700-1704 | Gene | denotes | ACE1 | Gene:1636 | |
| 78 | 1725-1733 | Disease | denotes | COVID-19 | MESH:C000657245 | |
| 79 | 1780-1792 | Disease | denotes | hypertensive | MESH:D006973 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 265-292 | Phenotype | denotes | susceptibility to infection | http://purl.obolibrary.org/obo/HP_0002719 |
| T2 | 1007-1019 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
| T3 | 1045-1057 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
| T4 | 1180-1192 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
| T5 | 1614-1626 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
| T6 | 1628-1648 | Phenotype | denotes | hypercholesterolemia | http://purl.obolibrary.org/obo/HP_0003124 |
LitCovid_AGAC_only
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| p149599s10 | 48-56 | Var | denotes | variants |